MiR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression

Bone

Volumn 51, Issue 3, 2012, Pages 498-505

  Wu, Tingting ^a   Xie, Ming ^a   Wang, Xiaojie ^a   Jiang, Xinquan ^a   Li, Jing ^a   Huang, Hui ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

BMP 2; MiR 155; Osteoblast differentiation; SAPK JNK; SOCS1

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; LUCIFERASE; MICRORNA 155; OSTEOCALCIN; PROTEIN C JUN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN; CELL STRAIN MC3T3 E1; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; OSTEOBLAST; OSTEOGENIC DIFFERENTIATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SOCS1 GENE; WILD TYPE;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; OSTEOGENESIS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864780886     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.05.013     Document Type: Article

References (43)

1. McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007, 31:729-734.
2. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biol Chem 2010, 147:35-51. [Review].
3. Kusumoto K., Bessho K., Fujimura K., Akioka J., Okubo Y., Wang Y., et al. Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates. J Int Med Res 2002, 30:251-259.
4. Vaidya R., Sethi A., Bartol S., Jacobson M., Coe C., Craig J.G. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008, 21:557-562.
5. Buma P., Arts J.J., Gardeniers J.W., Verdonschot N., Schreurs B.W. No effect of bone morphogenetic protein-7 (OP-1) on the incorporation of impacted bone grafts in a realistic acetabular model. J Biomed Mater Res B Appl Biomater 2008, 84:231-239.
6. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000, 141:3956-3964.
7. Nanes M.S. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321:1-15.
8. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916.
9. Beklen A., Ainola M., Hukkanen M., Gürgan C., Sorsa T., Konttinen Y.T. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007, 86:347-351.
10. Yamazaki M., Fukushima H., Shin M., Katagiri T., Doi T., Takahashi T., et al. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 2009, 284:35987-35995.
11. Mukai T., Otsuka F., Otani H., Yamashita M., Takasugi K., Inagaki K., et al. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 2007, 356:1004-1010.
12. Lee H.L., Yi T., Woo K.M., Ryoo H.M., Kim G.S., Baek J.H. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med 2010, 42:437-445.
13. Yan X., Chen Y.G. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling. J Biol Chem 2011, 434:1-10.
14. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
15. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007, 8:23-36.
16. Sato M.M., Nashimoto M., Katagiri T., Yawaka Y., Tamura M. Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun 2009, 383:125-129.
17. Huang J., Zhao L., Xing L., Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010, 28:357-364.
18. Schaap-Oziemlak A.M., Raymakers R.A., Bergevoet S.M., Gilissen C., Jansen B.J., Adema G.J., et al. MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev 2010, 19:877-885.
19. Mizuno Y., Yagi K., Tokuzawa Y., Kanesaki-Yatsuka Y., Suda T., Katagiri T., et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 2008, 368:267-272.
20. Itoh T., Takeda S., Akao Y. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. J Biol Chem 2010, 285:27745-27752.
21. Itoh T., Nozawa Y., Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009, 284:19272-19279.
22. Li Z., Hassan M.Q., Volinia S., van Wijnen A.J., Stein J.L., Croce C.M., et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008, 105:13906-13911.
23. Li H., Xie H., Liu W., Hu R., Huang B., Tan Y.F., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009, 119:3666-3677.
24. Li Z., Hassan M.Q., Jafferji M., Aqeilan R.I., Garzon R., Croce C.M., et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009, 284:15676-15684.
25. Hassan M.Q., Gordon J.A., Beloti M.M., Croce C.M., van Wijnen A.J., Stein J.L., et al. A network connecting Runx2, SATB2, and the miR-23a 27a 24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 2010, 107:19879-19884.
26. Rai D., Kim S.W., McKeller M.R., Dahia P.L., Aguiar R.C. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A 2010, 107:3111-3116.
27. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104:1604-1609.
28. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
29. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
30. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792, 497-505. [Review].
31. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc Natl Acad Sci U S A 2000, 97:5405-5410.
32. He Y., Zhang W., Zhang R., Zhang H., Min W. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem 2006, 281:5559-5566.
33. Torisu T., Nakaya M., Watanabe S., Hashimoto M., Yoshida H., Chinen T., et al. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology 2008, 47:1644-1654.
34. Gao J., Yang T., Han J., Yan K., Qiu X., Zhou Y., et al. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 2011, 112:1844-1856.
35. Eskildsen T., Taipaleenmäki H., Stenvang J., Abdallah B.M., Ditzel N., Nossent A.Y., et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A 2011, 108:6139-6144.
36. Strebovsky J., Walker P., Lang R., Dalpke A.H. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. FASEB J 2011, 25:863-874.
37. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002, 17:583-591.
38. Kimura A., Naka T., Nagata S., Kawase I., Kishimoto T. SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. Int Immunol 2004, 16:991-999.
39. Mizoguchi F., Izu Y., Hayata T., Hemmi H., Nakashima K., Nakamura T., et al. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 2010, 109:866-875.
40. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
41. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
42. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2009, 327:198-201.
43. Fabani M.M., Abreu-Goodger C., Williams D., Lyons P.A., Torres A.G., Smith K.G., et al. Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 2010, 38:4466-4475.